OSL Corpse, page-15

All those smart arses that say Oncosil hasn’t got enough data, etc, etc to support $70-$80 million EV.

Really? Not enough data they reckon?

There are drug companies listed on the ASX with virtually no data. Proof of concept, maybe a piss ant Phase 1 study, most likely single arm as well.

No Phase 2 study.

No Phase 3 study.

And no RCT! All single arm with very low patient data.

No Regulatory Approvals either. None. Let that sink in. None, zero, zilch.

Hardly any cash in the bank either, many of these exploratory drug companies.

No likely revenue either. None. Zero. Zilch.

No revenue on the horizon for most of these drug companies. None, zero, zilch.

CR almost a 100% certainty. Every year while they complete expensive trials.

No guarantees they will succeed to Phase 2 or Phase 3 either. None, Zero, Zilch.

Heaps of uncertainty. No Certainty of any success. None, Zero, Zilch.

Yet, the drug companies trade on multiples of Oncosil’s measly valuation. And the smart arses here on this forum tell us that Oncosil is fairly valued now and some even say overvalued!!!

What a JOKE! Oncosil was trading higher last year at circa above $150 million valuation with no CE Mark! Drug companies with nothing but a dream to sell have higher market valuations!

And then the smart ases will say, well it’s all down to poor management. That’s why Oncosil has a crap valuation. But then they also question the so called science behind the technology!!

But drug companies with no name Boards and bugger all scientific data can trade at higher multiples compared to Oncosil!!! Ridiculous argument. All BS if you ask me!!!

The market has a clear bias for unproven drug companies and not medical devices. Why? Because it’s more speculative. Drug companies offer that excitement to traders and speculators. A bit like an unproven gold mine. Market goes nuts as soon as a drill bit is taken off from the back of a Ute. Same as drug companies. All the speculators and racers jump on board before the release of Phase 1 results, Phase 2 results etc. “Buy the story, sell the fact.” All BS!!!

Oncosil’s time may well come. But it will be uphill given the current market preference for speculative drug and mining companies with very little substance. That’s my observation of what is occurring here. All my personal opinions. But that’s the way I see it.

Cheers

GW